RONKOLEYKIN (Roncoleukinum).

     Recombinant human analog of endogenous interleykina-2.

     It stimulates the growth, differentiation and proliferation of T and B-lymphocytes, monocytes, macrophages, cells and oligodendroglialnyh epidermalnyh Langergansa cells.

     Applied to treat septic different etiology of adult accompanied by immunization, as well as anticancer tool kidney cancer.

     Assign intravenous (drip) in the dose of 0.00025 grams (0.25 mg) to 0,002 grams (2 mg) one time a day; When septic able to introduce 2-3 times 0,0005-0,001 g ( 0,5-1 mg) with an interval of 2-3 days; kidney cancer with a five infusions of 0,001-0,002 grams (1-2 mg) with an interval of 2-3 days, repeat courses through 1-2 mon.

     Entering preparation may be an increase in body temperature.

     Ronkoleykin is not suitable for allergic reactions to Cytokines and yeast, autoimmune diseases, urological diseases, cardiovascular diseases and pregnancy.

     Product : dried powder for injection solutions to 0.00025; 0.0005 and 0.001 g (0.25; 0.5 and 1 mg N) (5).

Materials allowed to copy only with the active hyperlink to the handbook of medicines